Klivira
Request demo

Streamlining Pediatric Oncology Prior Authorizations with Waystar Clearinghouse Integration

Klivira optimizes the complex prior authorization landscape for pediatric oncology, ensuring efficient processing through your existing Waystar clearinghouse workflows. This integration is designed to accelerate approvals for critical childhood cancer treatments.

Pediatric oncology presents unique prior authorization challenges due to high-cost, rapidly evolving therapies and vulnerable patient populations. Revenue cycle directors and prior authorization coordinators require robust solutions that integrate seamlessly with their Waystar clearinghouse to manage these critical approvals without delaying care. Klivira addresses these specific demands, enhancing your operational efficiency.

Prior Authorization Complexities in Pediatric Oncology with Waystar

The clinical reality of pediatric oncology involves managing complex, often investigational, treatment protocols and high-cost therapies for rare diseases. Integrating prior authorization workflows with a clearinghouse like Waystar requires precision to ensure timely claims submission and reimbursement for services ranging from chemotherapy regimens to advanced cellular therapies. Klivira streamlines the data exchange, minimizing manual intervention in this critical revenue cycle segment.

Key Pediatric Oncology PA Triggers for Waystar Workflows

  • High-cost chemotherapy regimens, especially those prescribed under COG protocols.
  • CAR-T cell therapies and other advanced cellular immunotherapies.
  • Proton beam therapy and other specialized radiation oncology treatments.
  • Advanced diagnostic imaging, including PET/CT and high-field MRI.
  • Biologic agents and targeted therapies specific to pediatric malignancies.
  • Complex surgical procedures and bone marrow transplants.

EMR and Payer Touchpoints in Pediatric Oncology PA

Pediatric oncology workflows typically originate within EMR systems such as Epic Beacon or Cerner Millennium, where treatment plans and orders are documented. Klivira integrates with these EMRs to extract necessary clinical data for prior authorization, then facilitates the submission through Waystar’s clearinghouse functions. This includes managing X12 278 transactions, ePA submissions, and navigating specific payer portal requirements, ensuring all relevant clinical templates and documentation conventions are met.

Clinical Guidelines Informing Pediatric Oncology PA Submissions

  • NCCN Guidelines (specifically pediatric-focused recommendations).
  • ASCO Clinical Practice Guidelines for various childhood cancers.
  • Children's Oncology Group (COG) treatment protocols and associated evidence.
  • ACR Appropriateness Criteria for advanced diagnostic imaging.
  • Payer-specific medical policies informed by evidence-based medicine.

Optimizing the Pediatric Oncology Waystar Clearinghouse Workflow

Klivira enhances the Waystar clearinghouse workflow by automating the prior authorization process from initial order to payer approval. This reduces the administrative burden on prior authorization coordinators, minimizes potential for denials due to incomplete documentation, and accelerates the revenue cycle for pediatric oncology services. By ensuring that all necessary clinical evidence, specific to each patient's COG protocol or CAR-T regimen, is correctly packaged and submitted, Klivira helps maintain compliance and financial stability.

Frequently asked questions

How does Klivira integrate with Waystar for pediatric oncology prior authorizations?

Klivira integrates by extracting clinical data directly from your EMR, processing it against payer rules for pediatric oncology treatments, and then leveraging Waystar's clearinghouse capabilities for efficient X12 278 submission or routing to payer portals. This creates a streamlined, automated PA workflow.

What specific types of pediatric oncology treatments require prior authorization via Waystar?

High-cost treatments are primary triggers, including COG-protocol chemotherapy regimens, CAR-T cell therapies, proton beam therapy, advanced imaging (e.g., PET/CT), and specialized biologics. Klivira is designed to manage the unique documentation requirements for each of these within the Waystar workflow.

Can Klivira help manage COG protocol-specific PA requirements?

Yes, Klivira is configured to understand and support the specific documentation and submission requirements often associated with Children's Oncology Group (COG) protocols. Our system helps ensure that all necessary clinical evidence for these complex regimens is included in PA requests submitted via Waystar.

How does Klivira handle documentation for complex therapies like CAR-T within the Waystar workflow?

For complex therapies such as CAR-T, Klivira automates the extraction of detailed clinical notes, lab results, and treatment plans from the EMR. This critical documentation is then compiled and submitted with the PA request, ensuring that the Waystar clearinghouse can efficiently transmit comprehensive information to the payer for review.

What EMR systems are typically involved in pediatric oncology PA when using Waystar?

Common EMR systems involved in pediatric oncology prior authorization workflows that integrate with Waystar include Epic (especially Epic Beacon for oncology) and Cerner Millennium. Klivira's platform is built to integrate with these leading EMRs to facilitate seamless data flow for PA submissions.

Related coverage

Other pediatric-oncology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo